他汀类药物抗心房颤动作用

被引:7
作者
殷跃辉
石伟
机构
[1] 重庆医科大学附属第二医院心血管内科
关键词
他汀类药物; 心房颤动; 机制;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
他汀类药物可以减少心房颤动的发生率,其确切作用机制不明,可能与改变心肌离子通道与载体;抗炎作用;延缓心肌组织、电重构;改善自主神经功能等有关。
引用
收藏
页码:141 / 143
页数:3
相关论文
共 15 条
[1]   胺碘酮与辛伐他汀联用治疗阵发性心房颤动的临床研究 [J].
周培荣 ;
张士森 ;
刘玉珍 .
滨州医学院学报, 2007, (03) :183-184
[2]   中国心房颤动现状的流行病学研究 [J].
周自强 ;
胡大一 ;
陈捷 ;
张仁汉 ;
李奎宝 ;
赵秀丽 .
中华内科杂志, 2004, (07) :15-18
[3]  
Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study[J] . Giuseppe Patti,Massimo Chello,Dario Candura,Vincenzo Pasceri,Andrea D’Ambrosio,Elvio Covino,Germano Di Sciascio.Circulation . 2006 (14)
[4]   Effect of Atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion [J].
Ozaydin, Mehmet ;
Varol, Ercan ;
Aslan, Suleyman M. ;
Kucuktepe, Zehra ;
Dogan, Abdullah ;
Ozturk, Mustafa ;
Altinbas, Ahmet .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10) :1490-1493
[5]   Effect of C-reactive protein reduction on paroxysmal atrial fibrillation [J].
Dernellis, J ;
Panaretou, M .
AMERICAN HEART JOURNAL, 2005, 150 (05) :1064.e7-1064.e12
[6]   Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs [J].
Shiroshita-Takeshita, A ;
Schram, G ;
Lavoie, J ;
Nattel, S .
CIRCULATION, 2004, 110 (16) :2313-2319
[7]  
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial[J] . David W McCarey,Iain B McInnes,Rajan Madhok,Rosie Hampson,Olga Scherbakova,Ian Ford,Hilary A Capell,Naveed Sattar.The Lancet . 2004 (9426)
[8]   Analysis of Pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion [J].
Tveit, A ;
Grundtvig, M ;
Gundersen, T ;
Vanberg, P ;
Semb, AG ;
Holt, E ;
Gullestad, L .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (06) :780-782
[9]  
Differential Effects of Pravastatin, Simvastatin, and Atorvastatin on Ca2+ Release and Vascular Reactivity[J] . Belay Tesfamariam,Bruce H. Frohlich,Richard E. Gregg.Journal of Cardiovascular Pharmacology . 1999 (1)
[10]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952